Skip to Main Content

An official website of the United States government

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Name Principal Investigator Institution Study Date Approved Project ID
Diet, Metabolic Biomarkers and Lung Cancer Risk Martin Carl Tammemagi Brock University PLCO Nov 19, 2018 PLCO-418
Artificial Intelligence -based Computer Aided Early Diagnosis for low dose CT scans Jolu Ninan Abu Dhabi University NLST Nov 19, 2018 NLST-450
Establishing Equivalence of Commonly Used Physical Activity Measures Using Testing Equating Zezhao Chen University of Illinois at Urbana Champaign IDATA Nov 13, 2018 IDATA-28
Public Policy Recommendations Towards Colorectal Screenings Robert Henderson George Mason University PLCO Nov 13, 2018 PLCO-422
Evaluating genetic, clinical, and environmental risk factors for second primary lung cancer Summer Han Stanford University PLCO Nov 13, 2018 PLCO-423
Levels of Trimethylamine Metabolites and Their Associations with Dietary Intakes and Cardiometabolic Biomarkers: the TMAO Pooling Project Danxia Yu Vanderbilt University Medical Center PLCO Nov 2, 2018 PLCO-414
Predictors of second primary cancers among patients diagnosed with lung cancer in the PLCO trial Omar Abdel-Rahman Avicenna Oncology center PLCO Nov 2, 2018 PLCO-417
Future diagnosis prediction of lung cancer using convolutional and recurrent networks. Latifur Khan University of Texas at Dallas NLST Oct 31, 2018 NLST-449
Long Term Outcomes in Active Smokers Undergoing Lung Resection: An Analysis of the National Lung Cancer Screening Trial Joanna Sesti Robert Wood Johnson Barnabas Health NLST Oct 26, 2018 NLST-448
Lung Cancer Risk Prediction Modelling -- Extensions to the PLCOm2012 model Martin Carl Tammemagi Brock University PLCO Oct 26, 2018 PLCO-416
Clinical Cancer Data Analysis Canan Eren New Jersey Institute of Technology PLCO Oct 26, 2018 PLCO-410
Serum Metabolomic Profiling of Glioma Risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Jiaqi Huang NIH PLCO Oct 23, 2018 2017-1017
Physical activity, PSA levels, and screen-detected prostate cancers. Yelena Tarasenko Georgia Southern University PLCO Oct 23, 2018 PLCO-415
The role of environmental and socioeconomic factors in urologic malignancies Bashir Al Hussein New York Presbyterian Hospital NLST Oct 16, 2018 NLST-446
The use of data from Food Frequency Questionnaire (FFQ) for network analysis on cancer survivorship and food intake Linghan Qian Tufts University PLCO Oct 15, 2018 PLCO-405
Monitoring with Repeatedly Measured Markers: Application to longitudinal PSA measurements in PLCO Paramita Saha-Chaudhuri McGill University PLCO Oct 12, 2018 PLCO-408
Impact of colorectal cancer sidedness on the outcomes of colorectal cancer patients diagnosed within PLCO study Omar Abdel-Rahman Avicenna Oncology center PLCO Oct 12, 2018 PLCO-407
Outcomes of stage I non-small cell lung cancer patients treated with surgery versus radiation therapy within the NLST Omar Abdel-Rahman Avicenna Oncology center NLST Oct 11, 2018 NLST-445
Diabetes and Cancer Initiative Marc Gunter International Agency for Research on Cancer PLCO Oct 11, 2018 PLCO-397
Hormonal factors and risk of lung cancer: Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial and a meta-analysis of 10 cohort studies Zuo-Feng Zhang Fielding School of Public Health, University of California, Los Angeles, CA, USA PLCO Oct 11, 2018 PLCO-406